申请人:Chen Xin
公开号:US20110224191A1
公开(公告)日:2011-09-15
Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by Ron and/or Met.
以下公式式(I)的化合物,其定义如下:(I)药学上可接受的盐、合成、中间体、配方和治疗该疾病的方法,包括至少部分由Ron和/或Met介导的癌症。